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The purpose ofthis article is to describe the statistics and epidemiologicalfacts about the
most virulent epidemic ofour age, acquired immunodeficiency syndrome (AIDS). The
discussion arguesfor broadenedpublic policy to promote the surveillance ofcommunities
in order to enhance the effectiveness ofdata gatheringfor epidemiological reasoning,
analysis, and control measures. To accomplish these goals, the essential characteristics
ofepidemiology are defined. The use ofdeductive and inductive reasoning is applied to
describe and analyze known facts concerning the AIDS epidemic. Hypotheses are sug-
gestedfrom current amorphous and continually changing information to assist infurther
explanations ofthe epidemic and in the evaluation ofmethods ofprevention and control.
Current policiesfor sexually transmitted diseases are reviewed briefly to identify epidemi-
ological concerns, with the aim ofassisting policymakers. Implicationsforpublic policy
are discussed in the context ofseeking epidemiological informationfor the ultimate pro-
tection ofthe public good.
Epidemiology is logical thinking applied to health problems that threaten the public.
A more generally accepted definition of epidemiology is the study of patterns of
diseases and their precursors in communities; however, the essential elements of the epi-
demiological perspective are inductive and deductive processes of logical thought applied
to problems of sickness and health in groups. Many health professionals use the concepts,
processes, and results of epidemiological investigations to accomplish their goals. Epide-
miology crosses the conceptual delineations of disciplines concerned with health; it seeks
to identify health hazards to communities and evaluate the results of interventions, includ-
ing the effects of public policy on health matters. Its main purposes are to provide infor-
mation to achieve the goals of public health; to prevent and control sickness as well as
disease precursors in communities, and to promote community health.
Katherine Hill Chavigny is director of the Office ofRelated Health Professions and Nursing Affairs at the
American Medical Association in Chicago. Sarah L. Turner, an epidemiologist by training, teaches public-health
nursing at Lander College in Greenwood, South Carolina. Anne K. Kibrick is dean ofthe School ofNursing at
the University ofMassachusetts at Boston.
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Epidemiology and Public Policy
In the new federalism that is now in vogue, the states have assumed increased fiscal re-
sponsibilities. Reduction in federal support affects administrative and government deci-
sions at the state level. 1 Policies are codified and funds are allocated for state initiatives
that are influenced by many factors besides scientific logic. In regard to human immuno-
deficiency virus (HIV) infections, Massachusetts has enacted laws requiring written,
informed consent prior to testing for HIV antibody by physicians and health care facili-
ties. These statutes address confidentiality, insurance, and informed consent. 2 The laws
define AIDS as a handicap and invoke legal sanctions against discrimination toward per-
sons with AIDS; also, the disclosure of test results to any person except the patient is
prohibited by law. Informed consent of a person is required in written form before a test
may be obtained. These state statutes protect the rights of the individual in respect to the
group or community. State regulations must relate to and coordinate with national imper-
atives to effectively control epidemics.
At the federal and international levels, goals have been formulated, as follows, to coor-
dinate state activities to control sexually transmitted diseases (STDs): 3
1
.
To minimize disease exposure by reducing sexual intercourse with per-
sons who have a high probability of infection.
2 To prevent infection by increasing the use of condoms or other prophy-
lactic barriers.
3. To detect and cure disease by implementing screening programs, pro-
viding effective diagnostic and treatment facilities, and promoting
health-seeking behaviors.
4. To limit complications of infections by providing early treatment to
symptomatic and asymptomatic infected individuals.
5 To limit disease transmission within the community through the above
efforts.
These objectives affect current policy for all sexually transmitted diseases in the United
States, including the reporting and control of AIDS.
The syndrome known as AIDS is characterized by two inescapable but, it is hoped, not
immutable facts that demand special policy approaches: (1) it is an infection with ex-
tended periods of infectivity (the harboring of an infective agent), and (2) eventually, the
disease is fatal. It is crucial to recognize that the virus is carried and harbored by infected
persons long before symptoms of acute illness occur. Owing to the longevity and fatality
of HIV infection, the public requires policies for protection against a protracted, virulent,
and, often, sequestered hazard. But AIDS is also a social disease; its major risk groups
are associated with lifestyle behaviors such as homosexuality and illegal intravenous (IV)
drug use, about which the larger society has moral and ethical preconceptions. Public
policy, therefore, has to weigh civil liberties against the healthy survival of society.
Policymakers require facts to understand the risk of HIV infections, to ascertain the
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spread of the epidemic, and to assign resources. Basic scientific information is required
to make convincing arguments for change which can be justified as objective, unpreju-
diced, and realistic. Epidemiology provides a comprehensive resource of scientific infor-
mation about group problems for the use of administrators and legislators. All medical,
social, and basic sciences are marshaled and integrated in order to apply epidemiology to
the purpose of solving problems regarding the health of the community.
Policy for AIDS which meets the needs of each state requires reliable, valid, quantified
information for assisting policymakers in protecting the public and the individual. Na-
tional policy is based on the coordination and analysis of quantified data from state sur-
veillance systems. Access to accurate information is a basic prerequisite for solving
problems associated with community hazard. It is epidemiological practice to constantly
monitor communities and collect information. Each state has a surveillance system, inte-
grated on a national basis, to provide facts for scientific analysis. The civil concern to
protect homosexual and racial rights are real and are an irrevocable constitutional man-
date; however, protection of the group is an effective method of protecting individuals
within the community. Statutes and policies guard the individual by expressing group
decisions for mutual advantage of all people.
Methods used to determine the public good are all too frequently debatable issues.
Epidemiology attempts to provide a logical basis for assessing public hazards and the
effectiveness of communal solutions to protect the greatest good for all the people. Its
special contribution is that it provides a rational, objective groundwork on which to base
policy decisions. Facts are important to political arguments for opinion leaders, policy-
makers, and administrators. Valid information affords a means of allaying fear, provoking
concern, and setting priorities. Assessment of risk and assessment of effectiveness of
methods for the optimal protection of the people are prerequisite to setting cogent injunc-
tions.
The public health system was slow to respond to the AIDS epidemic; too little was
known about a slowly evolving but complex crisis that at first was not recognized as an
infectious disease. As a result, policies that govern infectious disease surveillance were
activated sluggishly. Partly because of this delay, there is a notable lack of reliable and
valid information to guide epidemiologists in their quest for group parameters to assist
policymakers. Measurement of community events are necessary to provide a scientific
basis for policies that are well-reasoned and just.
Issues in the Analysis of Epidemiological Information
Epidemiology quantifies the incidence of disease in communities. Epidemiological sur-
veillance provides objective data that allow comparisons between communities for deci-
sion making. But the mere collection of facts is never enough; to be meaningful, these
facts require analysis and interpretation. Epidemiology as a discipline provides the scien-
tific methods to analyze and optimize information through hypothesizing the cause of
monitored problems in communities and identifying the most effective methods of pre-
vention and control. These methods yield data to guide administrators and policymakers
at all levels of government.
Hypothesizing the cause of public health problems is the central theme in epidemiology.
Postulating the cause of health problems guides various strategies in analyzing observa-
tions and planning intervention in epidemic circumstances. In the interest of economy and
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effectiveness, it is important to choose a hypothesis that has the greatest power to produce
the true associations. This is no small task, and it depends on analysis of facts that can be
gleaned from the problem at issue, using hypothetical reasoning. The strength of the
postulated association between potential causes and effects can be tested through induc-
tive and deductive methods.
Scientific method is traditionally inductive, collecting observed facts to test a postulated
cause. Epidemiology utilizes this approach and claims the distinction of being a science
for public health. According to Karl Popper, all hypothetical reasoning is deductive,
rather than inductive. 4 In other words, a causal relationship is made first and then facts are
collected in support of the postulation. Popper also claims that refuting a hypothesis is
more powerful than verifying the postulated relationship; the process of refutation leads
to creative thinking and the selection of the most useful hypotheses. When refutation
through the application of present information to test the hypothesis fails, then the hypoth-
esis is worth testing through vigorous scientific research. Both approaches are available
to yield answers to the difficult, unsolved problems concerning HIV infections; however,
both methods of scientific inquiry require a body of known facts collected from the popu-
lation in order to be innovative as well as effective.
The formulation of causal hypotheses as applied to populations demands special meth-
ods not always used in the strictly experimental sciences. Epidemiology uses the terminol-
ogy of exposure for cause and effect for illness. There are several methods of assessing
the merits of any hypothesis. Critical challenges to hypothetical association between expo-
sure and effect include questions concerning (1) time order, (2) specificity, (3) consis-
tency, and (4) coherence. Time order requires the exposure to precede the effect (illness)
for the hypothetical association to be logical. Although it is known that some exposures
can cause more than one disease, specificity is the precision of the exposure to predict
illness and only that illness. Consistency is the ability of the hypothesized association to
persist regardless of time, place, and person; and lastly, coherence demands the biological
and clinical plausibility of the association. 5 In order to apply these (and other) logical
challenges and hypothesize productively and economically, the availability of facts about
the cases and their frequency is mandatory. Without facts — without the knowledge of
where and when the cases ofAIDS and the incidence of seroconversion (infection) are
occurring — hypothesized solutions for public policy are constrained and impaired.
Issues in Measurement of the Epidemic
The need to have valid and representative information to identify an emerging epidemic
and to hypothesize cause is demonstrated through the history of the emergence of the
epidemic. The first necessity that arose regarding the syndrome called AIDS was to es-
tablish that a problem existed and to describe its characteristics and distribution. Al-
though the first case of the disease syndrome was reported in 1978, it was not until 1981
that a cluster of several cases emerged indicating a possible problem. 6 Several outbreaks
of Pneumocystis carinii pneumonia and Kaposi's sarcoma, a rare form of cancer, were
reported to the Centers for Disease Control (CDC), the division of the U.S. Public Health
Service which is responsible for monitoring infectious diseases in the United States. Ex-
amination of this cluster of diseases disclosed that the problem appeared to be confined to
previously healthy, young, homosexual males. These differing diseases all showed the
common phenomena of the evidence of immunosuppression, depleting the ability of pa-
tients to regulate and overcome infection.
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Uniform case identification is crucial to any form of epidemiological investigation,
whether it is descriptive or etiologic. The designation of an AIDS case was particularly
difficult: not only does the disease syndrome present in several ways, but patients can
have recurrent episodes and different causes of death. For instance, according to the re-
port of the Committee for a National Strategy for AIDS, the major causes of death for
HIV infection through 1986 were Pneumocystis carinii (64 percent), Kaposi's sarcoma
(23 percent), and Candida esophagitis (7 percent).
7 More recent information from the
CDC indicates that the proportion of deaths due to Kaposi's sarcoma is decreasing to 11
percent relative to opportunistic infections such as Candida esophagitis. 8 As with most
mortality data, preexisting diagnoses are not shown. Reports usually indicate the fre-
quency of cases and the proportions of diagnoses relative to all cases. The number of
cases do not express the risk of AIDS and therefore do not relate to the community or
group risk. More important, many diagnoses associated with HIV infection, such as
AIDS dementia, are not systematically reported, although they are used within the new
definitions for diagnosing HIV infection. 9 The methodic, consistent categorizing of per-
sons with AIDS and the reporting of pre-mortality diagnoses are important for identifying
hypotheses that will yield salient knowledge for scientists, administrators, and govern-
ment leaders.
Because of the several diagnoses that accompany HIV infection as a result of reduced
immunity, it became clear that a collection of signs and symptoms, a syndrome, furnished
a preferred method of diagnosing the "cases" in the epidemic. In about 1982, the CDC
differentiated AIDS from AIDS-related complex (ARC) and persistent generalized lymph-
adenopathy (PGL) in order to designate different stages of the disease. At that time, it was
hypothesized that there was a linear progression from PGL to ARC to AIDS and so at
least fifty thousand ARC cases were not reported to the Centers for Disease Control for
inclusion in the epidemic. 10 The coherence of this postulate was soon shattered by the
observation that ARC patients died without progressing to AIDS; also, PGL was not nec-
essarily the first stage of what has subsequently been recognized as HIV infection. The
CDC surveillance system, based on state reports, has not included ARC or PGL as cases
of HIV infection in routine collection and reporting of epidemic data. The revised defini-
tions of 1987 do not include the denotations ARC or PGL; however, the same syndromes
are used for diagnosing the all-inclusive term of HIV infection or AIDS. Until the new
diagnostic criteria are applied consistently and until enough time has passed to compile
new rates rather than count cases, the extent of the epidemic remains equivocal.
The need for consistent, complete, valid information that is based on a comprehensive,
consistent case definition is aptly illustrated by the fact that the true extent of the epidemic
of all cases of HIV infection has not yet been detailed and made available to policymakers.
Importantly, the most recent definitions may improve case finding in the future, but it will
compromise any comparisons that may be made with information collected before Sep-
tember 1987, when the revised case definitions went into effect. The loss of comparable
baseline statistics will create difficulties for policymakers who wish to have evidence of
the effectiveness of regulations in slowing or deterring the spread of the epidemic.
Other epidemiological approaches are used to identify cases of infectious diseases. Any
test that can measure antibodies to a specific infectious agent or a generalized response to
infection is called a biological, epidemiological marker. The rationale for the use of the
marker is not only to assist in diagnosis of cases but also to screen populations in order to
identify the number of people who are infected in a community or in a subgroup of the
general population. Epidemiological markers provide serologic evidence of present or
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past infection from analysis of the blood. Blood contains red blood corpuscles and white
cells suspended in a yellow fluid called serum. Antibodies to HIV and other infectious
agents are found in sera that provide the serologic evidence to substantiate the presence of
infection. When the tests are administered to a large group, the level of infection within
the community or the proportion of those remaining susceptible to an infection can be
estimated.
In many cases of infection with diseases other than AIDS, the evidence of invasion of
the microbe is followed within a period of time, called the incubation period, by obvious
signs and symptoms of illness. In most infections, the incubation period is short and the
serum of the blood shows antibodies, a response to infection, almost at the same time that
illness occurs. In some diagnoses, such as syphilis or herpes hominis II, the symptoms
occur but may be too subtle to force an immediate consultation with a physician. After
invasion of the body with HIV, signs and symptoms of illness may be delayed indefinitely;
the only indication that the person is infected with the virus may be a positive blood test,
also called a positive serology. This means that an apparently healthy person is infected
with the virus and that it may be passed to others. The person is infected but has no diag-
nosed disease and may be unaware that he or she may be a danger to others.
The enzyme-linked immunosorbent assay, the ELISA test, made available in 1985, is an
epidemiological marker for measuring the presence of antibodies to the human immuno-
deficiency virus in the serum of the blood. A second test to corroborate a positive serol-
ogy is always required to verify the first measure, and the Western blot test is used when
the ELISA suggests the presence of HIV antibody. In HIV infection, the use of the tests
makes it possible to define infected populations who are without signs and symptoms of
acute illness. Tests are also used to verify the diagnosis ofAIDS when illness has already
occurred.
In 1987, the International Nomenclature Committee and others advised that the for-
merly used diagnostic term (AIDS) be discarded in favor of the global term HIV infec-
tion.
11 Almost simultaneously, diagnostic criteria for HIV infection were revised, and
signs and symptoms were regrouped. 12 These measures will assist in increasing the effec-
tiveness of quantifying cases for entry into the numerator of the rate, the basic statistic of
public health. Rates are important in epidemiology. The numerator is the frequency of
diagnosed cases; but it can also be restricted to the number of infected, asymptomatic
persons, such as those with positive blood (serology) tests. The denominator is the popu-
lation at risk of exposure to the hazard at the local, state, or national level. Accuracy of
rates depends on precise case identification and the size of the community where cases
occur. It is also heavily dependent on the identification and reporting of cases and infected
persons. Rational policy depends on access to valid rates to enhance the assessment of
public problems associated with diseases that threaten the well-being of the community.
Frequency of cases, the counting of the numerator of the rate, is often regarded as a ques-
tionable measure of the progress of an epidemic when the incubation period is lengthy, as
in HIV infection. Lack of methods of case identification that included all HIV infections
in the past has compromised the estimates of the extent of the epidemic and the hazard to
the public. In the same way, lack of reporting of persons with positive serology is a seri-
ous barrier to accurate assessments of group risk; it also makes any claims that the epi-
demic is slowing down open to question. 13
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Describing and Analyzing the Epidemic
The use of available facts to formulate hypotheses in epidemiology is illustrated by a se-
lective review of the evolution of the problem of AIDS. One of the first hypotheses con-
cerning the cause of the epidemic was based on the observation that the syndrome
occurred in male homosexual populations. 14 Several exposures common to this group
were examined. A reasonable association from early studies was thought to be the expo-
sure to sniffing amyl and butyl nitrite, drugs used to enhance orgasm. The amyl nitrites
are commonly used to relieve anginal pain. The causal association between the use of
these drugs and AIDS seemed to be refuted in later studies, mainly because the design had
not included a heterosexual control group; the sample was too restrictive. 15 Subsequently,
it became clear that the hypothesis did not meet the demand of criteria for establishing a
causal relationship, such as time order, specificity, and consistency, although the use of
these drugs may be a cofactor. The occurrence ofAIDS was not always preceded by use of
the nitrites; the taking of the drugs by homosexuals did not always predict AIDS, nor did
this association persist in groups such as hemophiliacs.
Other hypotheses were advanced. The autoimmune reaction is depleted when exposed
to spermatozoa that are forced into the bloodstream. It was thought that this antigenic
response was the cause of AIDS. This postulated association was thought to be biologi-
cally plausible (coherent), because immunosuppression and the increased occurrence of
tumors had been noted in primates who had had vasectomies. Although this hypothesis
has not yet been clearly refuted, it lost precedence when other information emerged from
increased surveillance and reporting.
Further analysis of available information showed similar patterns to hepatitis B virus
infection.
16 Rates of hepatitis B are highest in those who practice illegal intravenous drug
use and in persons with a history of venereal disease. Hepatitis B is spread through blood,
blood products, and sexual contact. The agent is a virus. Comparison between the group
pattern of hepatitis B and emerging facts about AIDS led to the hypothesis that AIDS, too,
is an infectious disease, a postulate that has now been verified and that meets all logical,
critical challenges.
The identification of what is now known as the human immunodeficiency virus, a ret-
rovirus with lentivirus characteristics, was a result of the work of a group of scientists
including Barne-Sinoussi, 17 Gallo,
18 and Levy 19 in 1983. As discussed earlier, the ELISA
test became available in 1985 — a direct result of identifying the causal agent. This epide-
miological marker traces the extent of the infection in the population; it is a screening
method for detecting the presence of asymptomatic infection as well as a diagnostic tool
for confirming cases. Lack of systematic screening policies has made the estimates of the
extent of the asymptomatic infection in the population unreliable. It was thought that there
might be between 1.5 million and 2 million seropositive people in the United States, but
this was a crude guess made in the absence of evidence. The reporting of seropositivity is
crucial to making the estimates valid, but policies to ensure the accurate collection of
these facts are still in debate. It is not surprising that the reported estimate was recently
revised and is thought to be much less, about 470,000, 20 although evidence is still sparse
to support this figure. The scope of the infected but submerged reservoir of infected peo-
ple is particularly troubling because the exact relationship of seroconversion to extant
illness is still not clear. The occurrence of AIDS after conversion to a positive ELISA test
used to be quoted as 1 : 5, or 20 percent. It is now thought that 50 percent of people with
positive serology may develop the disease. 21
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The description of the epidemic which was derived from analysis of collected observa-
tions showed that by the end of 1986, over 24,500 cases of AIDS had been reported to the
CDC. 22 It is thought that over 50,000 ARC cases had occurred during the same time pe-
riod.
23 By May 1987, the total had increased to 35,318 cases of AIDS. Of the total 35,318
cases, 92.6 percent occurred in males and 7.4 percent in females; 498 cases, or 1.4 per-
cent, were under the age of thirteen. 24
The profile or pattern of the disease has now taken shape. Male homosexuality and male
bisexuality account for 71 percent of the 35,318 cases, illegal intravenous drug use 14
percent, and male homosexuality with illegal intravenous drug use another 8 percent. 25
Illegal drug use is the major means of HIV transmission in females, followed by hetero-
sexual activity. When the mode of transmission of HIV infection is compared to white/
non-Hispanic, black/non-Hispanic, and Hispanic ethnic classifications, male homosex-
ual/bisexual activity was a major factor in white/non-Hispanic cases. Among blacks and
Hispanics, intravenous drug use was the main channel of transmission of the virus, and
heterosexual transmission of HIV was highest in blacks. 26
Few mandatory testing/screening programs for asymptomatic but infected people are in
place; however, the armed forces require ELISA screening for new applicants. Informa-
tion from this form of surveillance shows interesting epidemiological patterns. 27 From a
total of over three-quarters of a million applicants for military service, there were fewer
than two cases per thousand, or about a total of fifteen hundred persons with asymptomat-
ic infections. Anecdotal accounts of these data suggest that many of the seropositive appli-
cants assert they had no knowledge of their exposure to infected sources. 28 Also shown in
this report are the higher rates of seroconversion in blacks and Hispanics, confirming
other observations that rates of diagnosed AIDS in these minority groups are almost dou-
ble the rates of overt disease in the Caucasian/non-Hispanic group. 29
Facts describing the present status of the epidemic which may indicate intervention
methods for prevention and control include the following: Among female cases, 50 per-
cent are attributable to transmission by illegal intravenous drug use, 29 percent by hetero-
sexual spread, and 10 percent by blood or blood components. 30 Although females form a
small percentage of all reported cases, AIDS is associated with intravenous drug use twice
as much in women as in men; also in females, AIDS is associated with heterosexual activ-
ity fourteen times more than in males. 31 In the larger male groups, homosexual activity
and drug use, in that order, are the major forms of transmission.
The extent of the epidemic of HIV infection in women from 1981 through 1986 de-
scribes 1 ,819 cases, using the case definition that excluded cases ofARC 32 occurring
during this time period. For this reason, these figures should be regarded as very con-
servative estimates. Little is known about female homosexual transmission of the virus
between infected women. Usually, epidemiologists consider that compared to the male
homosexual/bisexual group, there is no equivalent risk group for females. 33 The predomi-
nant method of transmission of HIV infection to women is illegal use of intravenous
drugs, followed by heterosexual contact with a person at risk for AIDS. Because women
have the possibility of sexual contact with groups at high risk of HIV infection, such as
bisexual males, they are viewed as the interface between male homosexual/bisexual
groups and the heterosexual population, where seepage of the infection to non-high-risk
groups may take place. Following the progress of the epidemic through analysis of the
frequency of cases in women may be a method of categorizing the spread of the infection
into the heterosexual population. For instance, the proportion of cases in women which is
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ascribed to heterosexual transmission increased from 12 to 26 percent between 1982 and
the end of 1986. It is also obvious that infected women are the source of the transplacental
transmission that takes place from mother to infant, increasing the threat of AIDS to the
unborn. 34 Statistics in August 1987 indicated that, under the "old" CDC case definition,
40,051 cases had been reported to the CDC from fifty states in the Union. Fifty-eight
percent of these patients had died. 35 By mid-December, the total number of cases was
48,574. 36
Methods of Transmission ofHIV Infection
The transmission of an infective agent requires a reservoir that harbors the infective
source; a route of transmission or vehicle for spreading the organism; a susceptible host;
a portal of exit from the infected reservoir; and a portal of entry into the susceptible host.
The greater the knowledge about transmission of infectious disease, the more likely that
methods of prevention and control will be effective. Administrative and legislative initia-
tives utilize epidemiological information to break the chain of transmission, to plan serv-
ices, and to allocate resources.
The mode of transmission of HIV is similar to that of the virus of hepatitis B that
spreads through blood, blood products, and sexual intercourse. The transmission of the
hepatitis B virus differs from HIV because chronic carriers of the hepatitis B virus are
few, about 10 percent, and the incubation period is not longer than six months. It is also a
recognized occupational hazard to health care workers. 37 Hepatitis B is a reportable com-
municable disease that is under constant surveillance by public health authorities. It is
epidemic in proportions and has epidemiological tests or markers to screen high-risk
populations, a practice recommended by the Immunization Practice Advisory Committee.
A vaccine is available for primary prevention. 38
The reservoirs for HIV are infected asymptomatic and symptomatic persons. Once the
infection has taken place, the person remains infected and becomes a source of the virus.
High levels of infectivity are found in groups whose lifestyle, such as illegal IV drug use
or male homosexuality, places them at high risk. The chief vehicles through which the
disease is spread are blood, blood products, and semen. Portals of entry for infected se-
men to enter the body of a susceptible person are provided, probably, through trauma to
mucous membranes and through skin abrasions or open lesions. Another portal of entry is
provided through the direct injection of the virus into the bloodstream. 39 Methods of
spread are through sexual activities that may injure tissues and afford entry into the
bloodstream and (perhaps) through multiple sexual contacts in a short period of time. 40
Other routes of transmission are through illegal intravenous drug use, particularly the use
of shared needles, and through infected blood transfusions and blood products.
Portals of exit for infected secretions are provided through blood outlets such as bleed-
ing gums, accidental hemorrhage, and the emission of semen from infected persons. All
secretions for seropositive people have the potential to be infectious, including saliva and
vaginal secretions, possibly because the virus has been retrieved from the secretions; 41
however, transmission through these means is highly unlikely, because epidemiological
evidence indicates that casual social contact does not spread the disease. Direct contact
with an infected person or susceptible host with appropriate portals of entry seems the
necessary prerequisite for developing infection and subsequent AIDS.
Transmission of HIV infection between high- and low-risk populations is of great con-
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cern and requires further epidemiological studies to define accurately. The populations
with high and low rates interface through illegal drug use, bisexual behaviors, prostitu-
tion, blood transfusions, artificial insemination, and organ transplantation.
The risk of HIV infection for health care workers who deliver direct services is low, but
examination of information about the spread of disease to health workers illustrates the
need to protect portals of entry, such as skin abrasions, from accidental transmission. A
1986 study by the CDC showed that out of 750 physicians and nurses exposed to body
fluids of infected patients, only 3 workers, after complaining of needle sticks, were found
to have converted to positive antibody tests. 42 These professionals admitted to other risk
factors such as male homosexuality. In a larger study of 20,000 health care workers,
4 percent were seropositive; but it is thought that all workers with seroconversions had
other risk factors besides contact with HIV-infected patients. 43
It may be true that transmission occurs in health care workers without the presence of
any high-risk factors, but such transmission seems rare. Nine cases reported to the CDC
during 1987 did not admit to any high-risk lifestyles. 44 Anecdotal evidence implied that
seroconversion occurred from contact with infected fluid in the presence of injured skin. 45
Four of the cases had suffered needle-stick exposures; two others had had extensive con-
tact with infected body fluids but had failed to observe the recommended barrier precau-
tions to wear gloves. The remaining three cases illustrate the need to provide a portal of
entry for the virus to invade the body. A female worker with chapped hands applied pres-
sure to a bleeding arterial site to prevent hemorrhage during an emergency episode; sub-
sequently the worker had a positive ELISA test. In another case, the top of a 10 ml vacuum
blood collection tube flew off, and infected blood was splattered over the faces and in the
mouths of two workers, one ofwhom suffered from acne. The latter developed a positive
serology for HIV but the other worker remains seronegative. In another incident, a major
blood spill covered the gloved hands and forearms of a health care worker. She had der-
matitis in one ear and may have touched the ear during the incident; subsequently she
became seropositive. 46 Needle-stick injuries and exposure of mucous membranes to secre-
tion and blood infected with the virus do not appear inevitably to result in seroconversion;
however, the precise risk of transmission has not yet been defined. In spite of the general
low occupational risk, it seems that the possibility of transmission will increase as the
number of infected patients increases. 47
Studies of hemophiliacs with AIDS/ARC substantiate that social contact with family
and friends does not spread the disease. In a study of the family contacts of fifty children
and adults with diagnosed hemophilia, sexual contact between spouses was the only mode
of transmission of the disease. 48 Social interaction between friends and nonspouses with
antibody-positive, asymptomatic hemophiliacs did not spread the disease. The findings in
this study also showed that in comparison to the immune response in the social contacts of
the antibody-negative (uninfected) group of hemophiliacs, the immune response in the
social but nonsexual contacts of infected hemophiliacs was diminished. This suggests
hypotheses that perhaps nonsexual social exposure results in physiological responses of
the immune system, which may give some indications for research on an effective vac-
cine. See figure 1
.
The study by Jason and McDougal which was used as the source for figure 1 was small.
More recent studies substantiate that changes in the blood lymphocytes do not predict
clinical change.
49
Studies of the hemophiliac group establish that transmission of the virus
requires sexual contact or exposure to infected blood through a portal of entry that gives
access to the bloodstream. 50
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Figure 1
Diagnosis and HIV Antibody Status









(with signs and symptoms)
12 1 Spouse Out of
1 5 Contacts
ARC
(with signs and symptoms)
5 1 Spouse Out of
18 Contacts
Antibody-Positive
(infected but no signs or symptoms)





9 Cases Out of
21 Contacts
43 83
Rate of disease in sexual partners of AIDS/ARC hemophiliacs = 14% (2/l4)
Rate of disease in sexual partners of antib•ody-positive hemoplhiliacs = 0% (°/7 )
Significantly lower lymphocytes in social contacts with hemophiliacs with AIDS, ARC, and
antibody-positive serology than in contacts with antibody-negative hemophiliacs.
Source: Janine M. Jason, J. Steven McDougal, Gloria Dixon, et al. "HTLV-III/LAV Antibody and Immune
Status of Household Contacts and Sexual Partners of Persons with Haemophilia." Journal of the Ameri-
can Medical Association 255 (1986): 212-215.
Choice of sexual behavior in heterosexuals may influence transmission of HIV infec-
tion, given that one of the partners is a reservoir for the virus. A hypothesis that anal inter-
course may transmit the virus has been postulated from observations of the higher
frequency of AIDS in the receptive homosexual partner. This suggests that anal inter-
course may be a high-risk activity for females with an infected partner. The results of an
ongoing study of females exposed to seropositive partners indicate that there is increased
risk ofAIDS to support this hypothesis. 51 Specialists in obstetrics and gynecology advo-
cate tactful and sensitive inquiry into their patients' histories to obtain information on
frequency of anal intercourse in order to guide counseling. It is estimated from some
preliminary studies that 25 percent of American women engage in occasional anal inter-
course and that 10 percent ofwomen practice anal intercourse regularly. 52 53 These rates
are based on limited observations. Boiling and Voeller confirmed that information on
frequency of anal sex in women is sparse. 54 They estimate that the frequency of anal inter-
course is greater in cultural groups that use it as a method of contraception and preserva-
tion of virginity; nonetheless, it is thought that there is still a lower frequency of anal
intercourse in women than in homosexual men.
Heterosexual transmission is documented, 55 but the direction of transmission from
female to male was questioned. There is evidence that infected females practicing prosti-
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tution infect male heterosexuals. 56 This may be associated with the increased drug use in
this group. Though the risk appears small, it is expected that by 1991 heterosexual trans-
mission will account for perhaps 10 percent of all HIV infections. 57
Another mode of transmission between low- and high-risk groups is transplacental
spread to children born to infected mothers. A study in 1985 showed that of twenty-two
babies diagnosed with HIV infection who were born to sixteen mothers, fifteen were
asymptomatic at the time of birth of their first child with AIDS. Four of the mothers ad-
mitted to high-risk activities such as IV drug use and prostitution. 58 Other, more recent
studies indicate that the risk of transmission of the infection to the child seems to be 1:5,
or 20 percent. 59 - 60 6I
Methods of Prevention and Control
Decisions regarding the most effective methods of prevention and control require reliable
evidence of modes of transmission; valid estimates of the risk of exposure to the virus; and
knowledge of the virulence of the disease. Disease virulence (the serious consequences of
an infection) affects policy decisions regarding prioritization of goals, assignments of
funds, and allocation of resources. The virulence of a disease is measured by the case
fatality rate, which is the number of deaths occurring in diagnosed cases. At present, the
seven-year case fatality rate for AIDS is about 58 percent; in other words, more than half
the AIDS cases reported to the CDC between 1981 and 1987 have died. 62 Perhaps of
greater concern is that no diagnosed case of AIDS (or ARC) has recovered. 63 It is clear
that infection is extremely virulent, and this lends great urgency to the need to seek meth-
ods to control the spread of the epidemic.
Prevention and control methods block the invasion and transmission of the virus. One of
the most effective methods of preventing any infectious disease is through the immuniza-
tion of populations. This primary prevention technique protects against common infec-
tious diseases before infection takes place. For the immediate future, the availability of a
generalized effective vaccine for HIV infection seems remote. 64 Effective vaccines against
retrovirus infections have yet to be discovered. HIV has been described as a lentivirus that
has the characteristic of antigenic variation generated during replication of the virus. The
development of a vaccine that gives broadly effective immunity is quite difficult, on ac-
count of genomic diversity, or changes in the basic proteins in the chromosomes. The
existence of different strains of HIV creates a major obstacle for the generation of a sin-
gle, effective vaccine. This means that antibodies manufactured in response to the anti-
gens are not effective against successive generations of the virus. Should a vaccine
become available, such social concerns as how to evaluate its efficacy in populations will
have to be addressed. It is important to recognize that the effectiveness of vaccination
would have to be measured against baseline information that has already been collected
concerning rates of infection or seropositivity, and these rates are often questionable or
unavailable.
Public information and education, at present, are the most important means of primary
intervention to prevent the occurrence of the disease. Education for safer sexual practices
includes the use of the condom as a barrier to transmission of the virus during intercourse.
Determining the efficacy of these measures to change behavior and maintain behavioral
change will require reliable information. This information will be used to show decline in
the rate of increase of infection. It will also require information on the distribution and
characteristics associated with sexual practices and mores in several subgroups, such as
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the minorities. Several disciplines devoted to the study of behavioral phenomena need to
research these questions. A multidisciplinary approach crossing all professional bounda-
ries is required to develop the most effective methods of control of HIV infection. 65
Primary prevention — intervention in the transmission of disease before the disease
occurs — is the sine qua non of methods of preserving the health of the public. It is eco-
nomical; it is effective; it is the most humane approach to protecting the group and the
individuals within the group. Special kinds of scientific and epidemiological facts are
essential to the implementation of primary prevention. For instance, a hypothesis con-
cerning an effective vaccine must be scientifically plausible, and risk of acquiring the
disease after exposure must be verified so that vaccination can be timely. This information
is also important for conserving a safe blood supply.
It seems that the period between an exposure to an infected person and seroconversion
varies. The Institute of Medicine in late 1986 stated that seroconversion could occur as
early as six to eight weeks after exposure; however, the period is highly variable and may
extend as long as eight months. 66 More recently, it has been suggested that seroconversion
may occur up to twelve months after exposure. 67 The incubation period— the time be-
tween invasion and the occurrence of signs and symptoms of disease— is an important
epidemiological variable and is even more uncertain. Estimations made from infected
blood transfusions indicate an incubation period of about five years. 68 For adult cases not
associated with transfusions, the mean incubation period may be fifteen years. 69 These
analyses are compromised by limited data.
Reasons for the difficulty in identifying the incubation period are several. Establishing
the date of exposure is problematic, especially without established surveillance systems
denoting infected but asymptomatic persons. The incubation period may vary according
to mode of transmission, the age of the patient, and the initial concentration of the virus in
the infected substrate. Other strains of human immunodeficiency virus are appearing
which may lack the virulence of the microbe most frequently infecting the population.
Male-to-female, female-to-male transmission may be less effective than male-to-male
transmission.
70 Repeated exposure to the infected person may be necessary before the
susceptible partner contracts the virus, obfuscating the time of exposure. These factors
and others reflect the uncertainties of the discussion on the incubation period. They also
underscore the need for reliable documentation of infected persons to keep pace with the
ever changing state of the art concerning AIDS.
Secondary intervention is the early detection of infected people in the population.
ELISA and Western blot tests provide screening tools to identify the infected, asympto-
matic pool in the population, besides verifying the diagnosis in those with illness. Once
identified, those who are infected remain in the community as reservoirs for the virus for
a considerable length of time. Antiviral medication does not eliminate the virus; cure for
the infection is not yet within reach. For these reasons, HIV infection is called a chronic
disease. Moreover, because of the variability between seroconversion and overt illness,
the infected population does not always seek medical intervention; some may be unaware
that they have been exposed to those with high-risk lifestyles.
Infected populations fall into two groups: the asymptomatic, who feel well; and those in
whom symptoms are emerging or full-blown. Screening of populations would assist in
identifying infected patients, particularly those in whom infection is not suspected. The
greatest hazard to the community is the undetected infection. It has been long known in
infection control in hospitals that the greatest risk to hospitalized patients and staff is from
the "hidden," or undiagnosed, infected person.
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The asymptomatic, infected person is the greatest threat to the health of the community.
Screening is part of surveillance activities that include testing of high-risk groups attend-
ing venereal disease clinics, hospital emergency rooms, and jails. Testing for more than
one infection is possible and, often, routine. From the information obtained from these
tests, epidemiologists provide information for the community. Administrators learn the
degree of need in their locale and are able to plan resources to meet these needs. Local
communities are provided with evidence of the threat that exists in their cities and neigh-
borhoods and can organize programs to enhance education of the public. Politicians ob-
tain facts with which they can justify acquiring funds to focus on the greatest area of
concern and to encourage the promulgation of regulations to protect the public and the
individual. Surveillance also documents the spread or the lack of spread of epidemics into
low-risk groups; with a virulent disease such as AIDS, confirming a low prevalence of
infection can allay fears and offer reassurance to concerned citizens.
Many feel that the case yield (identified cases of infection) from screening of popula-
tions is necessary only where the group may have high levels of infected persons. The
danger of false positives is quoted as a reason to reduce screening activities. These argu-
ments have merit from a statistical point of view; however, the tests have over 98 percent
sensitivity and specificity — an excellent epidemiological marker to denote true cases and
true noncases. In populations of low prevalence, these figures deteriorate and the problem
of false positives increases. But the fact is that no test of positive serology is ever per-
formed without a repeat test. Even in situations where prevalence of HIV infection is low,
repeat testing increases the likelihood of accurate results. However, routine testing and
mandated testing must be differentiated in considering policy. Routine testing consists of
usual procedures of public health surveillance. Mandatory testing is supported by law.
Statutes requiring written permission for testing for AIDS — the Massachusetts law is an
example— create barriers to routine and confidential testing in clinics for sexually trans-
mitted diseases. This is important, because patients in these clinics constitute a high-risk
population for HIV infection. 71
The information gained from programs identifying infected populations is a powerful
tool for controlling spread of the infection among the public. Infected women can use the
information to make decisions about pregnancies. Infected partners can be taught to pre-
vent the further spread of the infection. In HIV infections, screening for seropositivity
before the signs and symptoms occur identifies a group that may be willing to assist re-
searchers in obtaining knowledge to obviate the development of the disease; this screening
also identifies those in need of the latest discoveries for treating the infection.
Surveillance information can also be used to plan tertiary prevention and the optimizing
of life for the chronically ill and the dying. Resources for meeting the needs of the af-
flicted and for tending to the dying are needed not only for reasons of humanitarianism,
but also to assure the best methods of controlling accidental transmission of the disease
during critically ill periods at home and in the hospital, when direct access to infected
blood of the patients may occur.
Other facts are required to formulate hypotheses that justify further research, which in
turn provides answers that eventually lead to intervention. Several hypotheses for epide-
miological research require immediate development, 72 not the least of which is the spread
of the disease into groups defined as low risk. Screening reveals populations where rates
of infection are low; the armed forces, a population with mandated testing, has low rates
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of seroconversion; however, the spread of the infection at the interface of high- and low-
risk groups may be increasing. 73 The risk of developing symptoms when a person has a
positive serology may be 50 percent, but this figure remains tentative, 74 with some even
projecting that, except for dying from competing causes before the symptoms of AIDS
manifest, eventual occurrence of the disease is inevitable.
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Hypotheses are legion. It is possible that a segment of the population is immune to the
virus; if this is so, it promotes areas of research with vast potential for prevention and
control. Minority groups, including mothers and babies, seem to die faster from HIV
infection than nonminority groups, but why this occurs is a challenging question. 76 Cen-
tral nervous system AIDS may be an autoimmune reaction that afflicts only hyperal-
lergenic subjects; if this is not the case, then other reasons for its apparently selective
occurrence must be sought. AIDS in Europe and Africa is primarily a heterosexual dis-
ease, for reasons that remain obscure. 77 HIV infection is a chronic illness that suppresses
the immune reaction to other infectious diseases; it is reasonable to predict a rise in other
infectious diseases such as tuberculosis and mononucleosis. 78 Hepatitis B, owing to simi-
lar modes of transmission, may rise concomitantly with the HIV epidemic. 79 Increased
surveillance of all infectious diseases is necessitated by the AIDS epidemic, and support
for the public health system that is already in place for public protection becomes an im-
perative.
The questions are compelling and the problem is critical. Surveillance information that
is salient, focused, and informative is urgently needed to enhance the contribution of
epidemiological research so that prevention and control methods can be determined.
Problems must be solved creatively so that a variety of methods of prevention can be iden-
tified through deductive and inductive reasoning; however, facts must be available from
which the most plausible and coherent hypotheses can be formulated. Assignment of
public and private funds may then be applied to the most productive research to assist in
solving the problem of HIV infection.
Discussion
Epidemiology, a public health science, is also called social medicine. The role of epidemi-
ology is to describe the health problems afflicting a society, seek the cause of hazards,
provide logical solutions, and evaluate interventions. Because epidemiology deals with
communities and provides information to protect social systems, it inevitably impacts
public policy. The origins of epidemiology lie deep in the history of infectious diseases
that have long plagued the human race. Its methods — which are designed to evaluate and
weigh evidence, test hypotheses, and provide answers that are derived from the group
experience— have established its success over time. Answers are shared with politicians,
administrators, and leaders, and, because of its application to public problems, epidemio-
logical research is often funded from public coffers. Where necessary, laws are made, on
the basis of scientific inquiry, with the goal of promoting realistic and defensible regula-
tions that are barriers to the spread of disease and that protect the rights of both the sick
and the well. But the degree to which any individual requires the protection of the statu-
tory system must be weighed and balanced against the degree of threat to the total commu-
nity, if only because individual safety often depends upon protective legislation that applies
to all. Objective, scientific observations of the spread of AIDS must be available to policy-
makers so that individual rights can be considered within the context of the public good.
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Compared to many infectious disease hazards that have occurred in the past, the HIV
epidemic has evolved slowly. Evidence has accumulated less quickly about a disease that
causes death and is unusual in its complexity. It has not been possible to marshal the facts
that were necessary to assuage fear and misconceptions that have spread within the com-
munity. The public health system was hampered by the lack of epidemiological markers
such as the ELISA test until the epidemic had been acknowledged for some time. This has
contributed to the delay in the customary public health methods of reporting, surveil-
lance, and routine testing. The complexity of adequate case definition has added to the
problems of activating public health reporting and surveillance systems for epidemiologi-
cal purposes. Accurate information gathered from the population is still needed to allay
fears, to document the lack of infection as well as its presence, and to establish the limits
of spread of HIV across the boundaries of high- and low-risk groups. Policy and regula-
tion need facts from adequate surveillance, accurate reporting, and scientific documenta-
tion of AIDS in order to support public health methods rather than obstruct the system.
Many precedents for public policy to control socially linked infections have already
been set. Syphilis has long been a disease that afflicted adults, that infected mothers, and
that spread to unborn infants. There was a time when it was incurable, inexorable, and
misunderstood. In the past, screening for antibodies to syphilis was mandated by law for
entry into the United States. Even today, testing for syphilis remains a statutory require-
ment in two states for obtaining marriage licenses. Costs of testing for syphilis are borne
by the applicants. As with any sexually transmitted disease, persons with positive serol-
ogy for syphilis require contact tracing. Social discrimination, confidentiality, and inva-
sion of privacy remain issues that cannot be avoided. The rights to confidentiality and
privacy are recognized and respected by the public health community.
Arguments against routine testing for HIV infection include prohibitive expense and the
lack of vaccine or treatment for contacts. Clearly, costs are a matter of administrative and
political priorities. Prevention methods for AIDS are only palliative, it is true; however, it
is hoped that this will change. Not only can contact tracing yield information for the com-
mon good; it can also identify people in jeopardy of contracting AIDS and other commu-
nicable diseases such as tuberculosis and hepatitis B. Those who are infected or in need
may be willing to become engaged in decisions to assist themselves and others as part of
prevention activities. Contact tracing will also provide a cadre of people who require
immediate treatment when the discovery of effective therapy is disclosed. Hepatitis B, a
disease associated with illegal IV drug use, was subject to all the usual public health ap-
proaches of surveillance, screening, and reporting, despite the problems of contact trac-
ing and confidentiality, even before a vaccine became available.
The American Medical Association promotes ethical standards for the practice of medi-
cine. In 1986, partly in response to the AIDS epidemic, 80 these standards were updated
and emphasized. When a physician provides treatment to a patient, confidentiality is the
hallmark of professional practice. Also, the physician may not refuse to properly inform
the patient of the diagnosis and treatment. The patient's consent is a prerequisite for the
sharing of information with any other person, and where statistical information is shared,
any personal identification must be deleted. These principles of medical ethics represent
ideal standards that can be overridden only in a court of law. Physicians are the gatekeep-
ers for patients' rights, especially for communicable diseases. With respect to HIV test-
ing, therefore, it is difficult to justify statutes that may enable a person to bypass physi-
cian intervention and care.
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Physicians safeguard the confidentiality of the patient and counsel patients about treat-
ment in order to ensure informed consent. Nowhere is this more important than with
social disease. Public health and preventive medicine have developed methods of contact
tracing which are committed to the ethos of respecting individual privacy while protecting
group concerns. Contacts are informed only with patient consent. Similarly, all epidemi-
ologists are obligated to respect confidentiality. Group information for analysis is filed
under conditions of strictest privacy, without any identifying information. The AMA has
recently reemphasized these high precepts for the guidance and direction of ethical con-
duct of medical practitioners.
Anonymity is preserved through universal mandates. In other words, when testing is
required routinely or by statute for groups such as prisoners, members of the armed
forces, persons seeking marriage, or patients attending clinics for sexually transmitted
diseases, no one is at risk of discrimination, because all must experience the same test in
obedience to the law. The results of the tests are group results — they are population-
based, and they supply a constant source of data for epidemiologists, who use them to
further the goals of prevention and control community health hazards. These ideals
should be sought and upheld by those who make public policy.
The public health community seeks to minimize disease through early detection and
treatment. These are accomplished through implementing screening programs, providing
effective diagnostic and treatment facilities, and promoting health-seeking behaviors.
Prevention and control include limiting the complications of infection by providing early
treatment to symptomatic and asymptomatic infected individuals and by limiting disease
transmission within the community. These efforts are communal and require dependable
surveillance systems that are accurate, reliable, and comprehensive. Enlightened public
policy is required to marshal the human and technical resources of the community to
protect individuals by protecting the public good.
Conclusions
Ongoing surveillance of virulent epidemics is an activity that is a national imperative. To
date, information on the size and extent of the epidemic is obscure, owing to a lack of
consistent, stable definitions of cases of illness for HIV infection and statutes that obstruct
routine tests of high-risk populations. We now have a method of identifying the asympto-
matic but infected populations — the hidden and sinister reservoir of a virulent virus. The
seropositive populations can be identified through screening activities that are part of
ongoing monitoring activities. Surveillance needs the support of political leadership. The
interface of high-risk and so-called low-risk groups is real. All estimates of risk of spread
of disease to groups with low-risk lifestyles are guesswork, based on inadequate and in-
complete data. In order to secure valid information for effective decision making, influ-
ential leaders must create policy that ensures the accuracy of statistics. Only then can
epidemiologists apply scientific principles for identifying the extent of the disease, the
risk to the unborn, and the effectiveness of methods of prevention and control. HIV infec-
tion is a national hazard and is the concern of all the people. The challenge for policyma-
kers is to assure protection for every human being while protecting the total community. *•*
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"I 'm really surprisedVm here. When I was originally diagnosed
over two and a halfyears ago, my doctor told me I wouldn 't be
alive today, and he certainly didn 't give me any indication that I
would be able to live a more productive life, and my life has
made a ISO-degree turn since diagnosis. Before diagnosis I was
an active alcoholic and drug addict and I've been cleanfor
almost two years. And I'm real gratefulfor that chance.
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